Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
autoimmune disease
Pharma
FDA shoots down Intercept's bid for full approval of Ocaliva
In the wake of an unfavorable advisory committee meeting, Intercept's bid to win full approval for its liver disease drug Ocaliva has come up short.
Fraiser Kansteiner
Nov 12, 2024 2:12pm
Autoimmune drugmaker Aurinia lays off 45% of workforce
Nov 7, 2024 9:44am
Accord snags £50M joint investment to boost UK manufacturing
Nov 5, 2024 9:45am
After an uphill struggle, Eliem becomes Climb Bio
Oct 3, 2024 11:26am
Intercept's Ocaliva nod in danger after negative FDA adcomm vote
Sep 16, 2024 10:40am
Novartis’ Fabhalta wins expanded FDA nod in IgAN
Aug 8, 2024 3:18am
